Key Takeaways
- Raymond James launched coverage with a Buy rating and an ambitious $800 price target, suggesting approximately 440% potential upside from SPCX’s latest close at $148.26
- In a bullish scenario, Citi projects $900 per share, which would place SpaceX’s valuation near $12 trillion
- Consensus analyst price target hovers around $240, representing 65% upside potential; analyst ratings include 22 Buys, 4 Holds, and 1 Sell
- Profitability isn’t anticipated until 2027, with substantial capital expenditures expected to maintain negative cash flow well beyond that timeline
- Following its IPO, SPCX reached an all-time peak of $225.64 but has since retreated to approximately $150, maintaining a 9.82% gain over its $135 IPO price
During premarket trading on Thursday, SpaceX (SPCX) stock climbed to $150.20, marking a 1.3% increase as analysts released a cascade of coverage reports following the company’s July 7 addition to the Nasdaq-100 index.
Space Exploration Technologies Corp., SPCX
On Tuesday, Raymond James analyst Brian Gesuale opened with a Buy recommendation and set a 12-month price target at $800. This projection indicates potential gains of approximately 440% from SPCX’s most recent closing price of $148.26. Gesuale’s investment case emphasizes SpaceX’s position as a transformative infrastructure company, highlighting Starship and Starlink as primary growth catalysts.
Gesuale wasn’t the only optimistic voice. The surge in new analyst ratings elevated the overall consensus to Strong Buy territory — comprising 22 Buy recommendations, 4 Hold ratings, and a single Sell. According to TipRanks data from July 9, the average analyst price target now registers at $245.96.
However, the most striking valuations emerge from bullish scenario projections.
Citi analyst John Godyn maintains an official $200 price target but presents a bull-case scenario of $900 per share — a valuation that would position SpaceX around $12 trillion, surpassing tech titans like Microsoft, Amazon, or Tesla. Godyn characterizes the $200 target as “a milestone along the path to $900-plus,” dependent on successfully demonstrating critical engineering achievements at commercial scale.
Morgan Stanley’s Adam Jonas officially targets $300, with an optimistic scenario reaching $600. His upside projection assumes Starship achieves operational status this year, the Terafab semiconductor manufacturing facility commences production, and orbital AI satellites deploy successfully. Conversely, his pessimistic scenario lands at $75 — predicting Starship won’t reach full operational capability until 2029.
Cantor Fitzgerald’s Colin Canfield employs a more conventional valuation methodology. His bullish projection utilizes 2030 earnings per share of approximately $11 with a 100x multiple, discounted to roughly $740 per share. His bearish case applies $8 EPS with a 20x multiple, yielding approximately $100.
Starship Dominates Analyst Narratives
Throughout nearly every analyst report, one element remains central: Starship. The massive, fully reusable launch vehicle remains in the testing phase but promises to revolutionize orbital access costs — potentially reducing expenses from thousands of dollars per kilogram to mere tens or hundreds. Reduced launch economics would enable unprecedented scaling for Starlink, which currently serves over 10 million subscribers while maintaining profit margins exceeding 60%.
The substantial gap between optimistic and pessimistic projections is remarkably wide, even considering growth stock volatility. This divergence underscores the considerable uncertainty surrounding SPCX’s trajectory.
Financial Fundamentals Remain Developing
SpaceX isn’t projected to achieve profitability until 2027, based on FactSet estimates. Even following that milestone, substantial capital investments suggest the company will probably maintain negative cash flow for multiple additional years — necessitating continued reliance on debt and equity financing to support its expansion plans.
SPCX achieved an all-time high of $225.64 merely four days following its initial public offering before experiencing a significant correction. The stock has stabilized around $150 throughout the past week, approximately matching its June 12 opening price, while maintaining roughly 9.82% appreciation above its $135 IPO price.


